Abstract Cannabinoids, particularly Δ9‐tetrahydrocannabinol (THC) and cannabidiol (CBD), have gained popularity as alternative sleep aids; however, their effects on sleep…
Abstract Background and Purpose: Epilepsy is a common indication for medicinal cannabis (MC) prescription in Australia. Despite legal MC products…
Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s00406-025-01983-4. Article type: Research Article Keywords: Cannabidiol, Neuroimaging, Cue…
Abstract Background: Although clozapine is the most effective antipsychotic for people with treatment-resistant schizophrenia (TRS), only 40% of people with…
Abstract Current treatments for alcohol use disorders (AUD) have limited efficacy. Recently, Cannabidiol (CBD) has been examined in a multitude…
Abstract Background: Cannabis was legalised for medical purposes in 2016. Uptake was initially slow, but since 2019 there has been…
Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s00213-024-06595-9. Article type: Research Article Keywords: cannabinoids, cognition, driving…
Abstract The underlying neurobiological mechanisms of cannabidiol’s (CBD) management of alcohol use disorder (AUD) remains elusive. Aim We conducted a…
Abstract Point‐of‐collection testing (POCT) devices are widely used in roadside and workplace drug testing to identify recent cannabis use by…
Abstract Introduction: Prescribed medicinal cannabis (MC) is an increasingly common prescription in Australia for treating pain, anxiety, and sleep disorders.…